Literature DB >> 25285270

Doing Damage in Delirium: The Hazards of Antipsychotic Treatment in Elderly Persons.

Sharon K Inouye1, Edward R Marcantonio1, Eran D Metzger2.   

Abstract

Entities:  

Year:  2014        PMID： 25285270      PMCID： PMC4180215          DOI： 10.1016/S2215-0366(14)70263-9

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  23 in total

Review 1.  Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.

Authors:  Alicia Ruelaz Maher; Margaret Maglione; Steven Bagley; Marika Suttorp; Jian-Hui Hu; Brett Ewing; Zhen Wang; Martha Timmer; David Sultzer; Paul G Shekelle
Journal:  JAMA       Date:  2011-09-28       Impact factor: 56.272

Review 2.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

Review 3.  Adverse effects of antipsychotic medications.

Authors:  John Muench; Ann M Hamer
Journal:  Am Fam Physician       Date:  2010-03-01       Impact factor: 3.292

4.  Multicomponent targeted intervention to prevent delirium in hospitalized older patients: what is the economic value?

Authors:  J A Rizzo; S T Bogardus ; L Leo-Summers; C S Williams; D Acampora; S K Inouye
Journal:  Med Care       Date:  2001-07       Impact factor: 2.983

5.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

Review 6.  Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review.

Authors:  Joseph H Flaherty; Jeffrey P Gonzales; Birong Dong
Journal:  J Am Geriatr Soc       Date:  2011-11       Impact factor: 5.562

7.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

8.  Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.

Authors:  Chi-Shin Wu; Chao-Cheng Lin; Chia-Ming Chang; Kuan-Yi Wu; Hsin-Yi Liang; Ya-Wen Huang; Hui-Ju Tsai
Journal:  J Clin Psychiatry       Date:  2013-09       Impact factor: 4.384

9.  Antipsychotic drug use and risk of pneumonia in elderly people.

Authors:  Wilma Knol; Rob J van Marum; Paul A F Jansen; Patrick C Souverein; Alfred F A M Schobben; Antoine C G Egberts
Journal:  J Am Geriatr Soc       Date:  2008-02-07       Impact factor: 5.562

10.  Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium.

Authors:  Karalea D Jasiak; Ellen A Middleton; James M Camamo; Brian L Erstad; Linda S Snyder; Yvonne C Huckleberry
Journal:  J Pharm Pract       Date:  2012-11-26
View more
  17 in total

1.  Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis.

Authors:  Yi-Cheng Wu; Ping-Tao Tseng; Yu-Kang Tu; Chung-Yao Hsu; Chih-Sung Liang; Ta-Chuan Yeh; Tien-Yu Chen; Che-Sheng Chu; Yutaka J Matsuoka; Brendon Stubbs; Andre F Carvalho; Saho Wada; Pao-Yen Lin; Yen-Wen Chen; Kuan-Pin Su
Journal:  JAMA Psychiatry       Date:  2019-05-01       Impact factor: 21.596

2.  Antipsychotics and the Risk of Aspiration Pneumonia in Individuals Hospitalized for Nonpsychiatric Conditions: A Cohort Study.

Authors:  Shoshana J Herzig; Mary T LaSalvia; Elliot Naidus; Michael B Rothberg; Wenxiao Zhou; Jerry H Gurwitz; Edward R Marcantonio
Journal:  J Am Geriatr Soc       Date:  2017-11-02       Impact factor: 5.562

Review 3.  [Treatment with psychotropic agents in patients with dementia and delirium : Gap between guideline recommendations and treatment practice].

Authors:  Walter Hewer; Christine Thomas
Journal:  Z Gerontol Geriatr       Date:  2017-01-25       Impact factor: 1.281

4.  Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission.

Authors:  Lisa M Kalisch Ellett; Nicole L Pratt; Jemisha Apajee; Elizabeth E Roughead
Journal:  Int J Clin Pharm       Date:  2019-06-25

5.  Anticholinergic Exposure During Rehabilitation: Cognitive and Physical Function Outcomes in Patients with Delirium Superimposed on Dementia.

Authors:  Ann Kolanowski; Jacqueline Mogle; Donna M Fick; Noll Campbell; Nikki Hill; Paula Mulhall; Liza Behrens; Elise Colancecco; Malaz Boustani; Linda Clare
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-31       Impact factor: 4.105

6.  Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors.

Authors:  Shoshana J Herzig; Michael B Rothberg; Jamey R Guess; Jennifer P Stevens; John Marshall; Jerry H Gurwitz; Edward R Marcantonio
Journal:  J Am Geriatr Soc       Date:  2016-02       Impact factor: 5.562

7.  Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures.

Authors:  Joseph T Hanlon; Todd P Semla; Kenneth E Schmader
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

8.  The American Geriatrics Society/National Institute on Aging Bedside-to-Bench Conference: Research Agenda on Delirium in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-03-31       Impact factor: 5.562

9.  Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: a qualitative descriptive study.

Authors:  Emily J Tomlinson; Helen Rawson; Elizabeth Manias; Nicole Nikki M Phillips; Peteris Darzins; Alison M Hutchinson
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

Review 10.  Recent Insights on Prevalence and Corelations of Hypoactive Delirium.

Authors:  Vaios Peritogiannis; Maria Bolosi; Charalampos Lixouriotis; Dimitrios V Rizos
Journal:  Behav Neurol       Date:  2015-08-10       Impact factor: 3.342
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.